Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion (TAF)
A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolution Matrix) in Subjects Undergoing Foot and Ankle Fusion
Sponsor: Orthofix Inc.
This observational or N/A phase trial investigates Calcaneocuboid Arthrodesis and Double Arthrodesis (i.e. Calcaneocuboid and Talonavicular) and is currently completed. Orthofix Inc. leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2021 — Jul 2024 [monthly]
Completed
Phase: NA → None
-
Jan 2021 — Nov 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Orthofix Inc.
For direct contact, visit the study record on ClinicalTrials.gov .